Literature DB >> 3397178

Virulence properties and protective efficacy of the capsular polymer of Haemophilus (Actinobacillus) pleuropneumoniae serotype 5.

T J Inzana1, J Ma, T Workman, R P Gogolewski, P Anderson.   

Abstract

The role of the capsule of Haemophilus (Actinobacillus) pleuropneumoniae serotype 5 in bacterial virulence, and the protective efficacy of antibody to serotype 5 capsule was investigated. Encapsulated H. pleuropneumoniae serotype 5 were resistant to killing by complement and antibody to capsule or somatic antigens, whereas a noncapsulated mutant was sensitive to killing by the alternative complement pathway alone. Antiserum to whole H. pleuropneumoniae serotype 5 bacteria or monospecific antiserum to capsule was capable of opsonizing bacteria of the homologous serotype for phagocytosis by swine polymorphonuclear leukocytes but was not opsonic for a heterologous serotype. An immunoglobulin M monoclonal antibody to the serotype 5 capsule was not opsonic for any serotype. Mice were protected against lethal, intranasal challenge with the homologous or heterologous serotype after immunization with live encapsulated or noncapsulated bacteria, but not after immunization with killed bacteria, lipopolysaccharide, or a capsule-protein conjugate vaccine. The protection induced by immunization with live bacteria was transferred to nonimmune, syngeneic mice by serum but not by spleen cells. Nonimmune pigs passively immunized with monospecific swine serum to capsule were protected from lethal infection but not from development of hemorrhagic lung lesions, whereas pigs passively immunized with swine antiserum to live bacteria did not develop severe respiratory lesions. Thus, the capsule of H. pleuropneumoniae serotype 5 was inhibitory to the bactericidal activity of serum and was antiphagocytic. Antibody to the capsule was opsonic but was not fully protective.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3397178      PMCID: PMC259496          DOI: 10.1128/iai.56.8.1880-1889.1988

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  38 in total

1.  STUDIES ON THE CHEMICAL NATURE OF THE SUBSTANCE INDUCING TRANSFORMATION OF PNEUMOCOCCAL TYPES : INDUCTION OF TRANSFORMATION BY A DESOXYRIBONUCLEIC ACID FRACTION ISOLATED FROM PNEUMOCOCCUS TYPE III.

Authors:  O T Avery; C M Macleod; M McCarty
Journal:  J Exp Med       Date:  1944-02-01       Impact factor: 14.307

Review 2.  Phagocytosis of microorganisms.

Authors:  M A Horwitz
Journal:  Rev Infect Dis       Date:  1982 Jan-Feb

3.  Effect of Haemophilus influenzae type b lipopolysaccharide on complement activation and polymorphonuclear leukocyte function.

Authors:  T J Inzana; M F Tosi; S L Kaplan; D C Anderson; E O Mason; R P Williams
Journal:  Pediatr Res       Date:  1987-12       Impact factor: 3.756

4.  Growth and hemolysin production by Haemophilus pleuropneumoniae cultivated in a chemically defined medium.

Authors:  J R Maudsley; S Kadis
Journal:  Can J Microbiol       Date:  1986-10       Impact factor: 2.419

5.  Resistance of C3H/HeJ mice to the effects of Haemophilus pleuropneumoniae.

Authors:  B W Fenwick; B I Osburn; H J Olander
Journal:  Infect Immun       Date:  1986-09       Impact factor: 3.441

6.  Influence of the Escherichia coli capsule on complement fixation and on phagocytosis and killing by human phagocytes.

Authors:  M A Horwitz; S C Silverstein
Journal:  J Clin Invest       Date:  1980-01       Impact factor: 14.808

7.  Studies on immunity to Haemophilus pleuropneumoniae infections in mice.

Authors:  T N Sebunya; J R Saunders
Journal:  Am J Vet Res       Date:  1982-10       Impact factor: 1.156

8.  Haemophilus parahaemolyticus serotypes. Pathogenicity and cross immunity.

Authors:  R Nielsen
Journal:  Nord Vet Med       Date:  1979-10

9.  Evaluation of a Killed Vaccine Against Porcine Pleuropneumonia Due to Haemophilus pleuropneumoniae.

Authors:  R Higgins; S Larivière; K R Mittal; G P Martineau; P Rousseau; J Cameron
Journal:  Can Vet J       Date:  1985-02       Impact factor: 1.008

10.  Haemophilus pleuropneumoniae serotypes--cross protection experiments.

Authors:  R Nielsen
Journal:  Nord Vet Med       Date:  1984 Jul-Aug
View more
  25 in total

1.  The N-terminal domain of RTX toxin ApxI of Actinobacillus pleuropneumoniae elicits protective immunity in mice.

Authors:  J N Seah; J Frey; J Kwang
Journal:  Infect Immun       Date:  2002-11       Impact factor: 3.441

2.  Inhibition of bactericidal activity of anticapsular antibody by nonspecific antibodies reactive with surface-exposed antigenic determinants on Actinobacillus pleuropneumoniae.

Authors:  F A Udeze; S Kadis
Journal:  Infect Immun       Date:  1992-09       Impact factor: 3.441

3.  Use of an Actinobacillus pleuropneumoniae multiple mutant as a vaccine that allows differentiation of vaccinated and infected animals.

Authors:  Alexander Maas; Ilse D Jacobsen; Jochen Meens; Gerald-F Gerlach
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

4.  Hemolysin patterns of Actinobacillus pleuropneumoniae.

Authors:  J Frey; J Nicolet
Journal:  J Clin Microbiol       Date:  1990-02       Impact factor: 5.948

5.  Convalescent pigs are protected completely against infection with a homologous Actinobacillus pleuropneumoniae strain but incompletely against a heterologous-serotype strain.

Authors:  T Cruijsen; L A van Leengoed; M Ham-Hoffies; J H Verheijden
Journal:  Infect Immun       Date:  1995-06       Impact factor: 3.441

6.  Effects of Actinobacillus pleuropneumoniae hemolysin on porcine neutrophil function.

Authors:  F A Udeze; S Kadis
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

Review 7.  Virulence factors of Actinobacillus pleuropneumoniae involved in colonization, persistence and induction of lesions in its porcine host.

Authors:  Koen Chiers; Tine De Waele; Frank Pasmans; Richard Ducatelle; Freddy Haesebrouck
Journal:  Vet Res       Date:  2010-06-15       Impact factor: 3.683

8.  Efficacy of a cell extract from Actinobacillus (Haemophilus) pleuropneumoniae serotype 1 against disease in swine.

Authors:  P J Fedorka-Cray; M J Huether; D L Stine; G A Anderson
Journal:  Infect Immun       Date:  1990-02       Impact factor: 3.441

9.  Purification and characterization of a protease from Actinobacillus pleuropneumoniae serotype 1, an antigen common to all the serotypes.

Authors:  E Negrete-Abascal; V R Tenorio; A L Guerrero; R M García; M E Reyes; M de la Garza
Journal:  Can J Vet Res       Date:  1998-07       Impact factor: 1.310

10.  Modulation of gene expression in Actinobacillus pleuropneumoniae exposed to bronchoalveolar fluid.

Authors:  Abdul G Lone; Vincent Deslandes; John H E Nash; Mario Jacques; Janet I Macinnes
Journal:  PLoS One       Date:  2009-07-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.